Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Marinus Pharmaceuticals Inc. logo

Marinus Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 86 M  90-day average vol: 2,175,902

Previous close: 1.46  Open: 1.45  Bid: 1.43  Ask: 1.5
52 week range    
Last updated: Monday 17th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)

MRNS Income Statement

AccruedPreferredStockDividends3 M
Basic EPS from continuing operations-2.8-2.69-0.51-2.63
Basic EPS total-2.8-2.69-0.51-2.63
Basic weighted shares outstanding2 M4 M5 M6 M10 M14 M27 M37 M39 M54 M
Cost of sales1 M150000.02 M
Depreciation unreconciled-100000.0-200000.0
Diluted EPS total-8.68-6.68-5.88-3.2-3.6-3.96-2.8-2.69-0.51-2.63
Diluted normalized net income/share-3.96-2.69-0.51-2.63
Diluted weighted shares outstanding1 M4 M5 M6 M10 M14 M37 M39 M54 M
GeneralAndAdministrativeExpense3 M6 M6 M7 M9 M11 M19 M37 M57 M61 M
Gross operating profit2 M14 M25 M29 M
Income before tax-11 M-25 M-29 M-19 M-37 M-54 M-67 M-99 M-16 M-143 M
Income taxes3 M-2 M
Interest income12000.064000.0128000.0324000.0454000.0354000.0499000.080000.02 M8 M
InterestExpenseNonOperating117000.0475000.0464000.0159000.03 M11 M17 M
MiscOtherSpecialCharges1 M-65000.0-20000.0-1000.0-53000.02 M7 M4 M13 M
Net income from total operations-11 M-25 M-29 M-19 M-37 M-54 M-67 M-99 M-20 M-141 M
NetIncomeCommonStockholders-13 M-25 M-29 M-19 M-37 M-54 M-76 M-99 M-20 M-141 M
NetIncomeContinuousOperations-11 M-25 M-29 M-19 M-37 M-54 M-67 M-99 M-20 M-141 M
NetNonOperatingInterestIncomeExpense-105000.0-411000.0-336000.0165000.0454000.0354000.0499000.0-3 M-8 M-9 M
Normalized income-78 M-144 M
Operating income-12 M-24 M-28 M-19 M-37 M-54 M-68 M-97 M-113 M-131 M
Operating income before depreciation (EBITDA)-11 M-24 M-28 M-19 M-37 M-54 M-67 M-95 M-4 M-124 M
OperatingExpense12 M24 M28 M19 M37 M54 M70 M111 M137 M161 M
Other income net-1 M65000.020000.01000.053000.0-2 M-7 M-4 M-13 M
OtherGandA3 M6 M6 M7 M9 M11 M19 M37 M57 M61 M
OtherunderPreferredStockDividend3 M
PreferredStockDividends3 M
RentAndLandingFees3 M6 M6 M7 M9 M
Research & development expense9 M19 M22 M12 M28 M43 M51 M74 M80 M99 M
ResearchExpense9 M19 M22 M12 M28 M43 M51 M74 M80 M99 M
Revenue per share549000.02 M2 M
Selling Gen & administrative expense3 M6 M6 M7 M9 M11 M19 M37 M57 M61 M
Total Income available for interest expense (EBIT)-11 M-24 M-28 M-19 M-37 M-54 M-67 M-96 M-6 M-126 M
Total common shares outstanding4 M5 M5 M10 M13 M22 M37 M37 M50 M55 M
Total net income-11 M-25 M-29 M-19 M-37 M-54 M-67 M-99 M-20 M-141 M
Total ordinary shares55 M55 M55 M55 M55 M55 M55 M55 M55 M55 M
Total revenues2 M9 M19 M20 M
TotalExpenses12 M24 M28 M19 M37 M54 M70 M112 M137 M162 M
TotalRevenue2 M15 M25 M31 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University